東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

UCP2-Dependent Changes in Mitochondr...

Hass, Daniel T.

FindBook

Google Book

Amazon

博客來

UCP2-Dependent Changes in Mitochondrial Dynamics Protect the Retina from Glaucoma.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	UCP2-Dependent Changes in Mitochondrial Dynamics Protect the Retina from Glaucoma./
作者:	Hass, Daniel T.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
面頁冊數:	132 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-12, Section: B.
Contained By:	Dissertations Abstracts International80-12B.
標題:	Neurosciences. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13917913
ISBN:	9781392318461

UCP2-Dependent Changes in Mitochondrial Dynamics Protect the Retina from Glaucoma.
Hass, Daniel T.

UCP2-Dependent Changes in Mitochondrial Dynamics Protect the Retina from Glaucoma. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 132 p.

Source: Dissertations Abstracts International, Volume: 80-12, Section: B.

Thesis (Ph.D.)--The Pennsylvania State University, 2019.

Glaucoma is a neurodegenerative disorder characterized by mitochondrial dysfunction and an increase in oxidative damage, leading to progressive retinal ganglion cell (RGC) degeneration. The oxidative status of RGCs is regulated intrinsically and also extrinsically by retinal glia. The mitochondrial uncoupling protein 2 (UCP2) relieves oxidative and neuronal damage in a variety of neurodegenerative disease models. However, the impact of Ucp2 on cell survival during sub-acute and chronic neurodegenerative conditions is not yet clear. Herein, we test the hypothesis that increased Ucp2 expression will improve retinal ganglion cell survival in a mouse model of glaucoma. We show that increasing retinal ganglion cell but not glial Ucp2 expression in transgenic animals decreases glaucomatous RGC death, but also that the PPAR-γ agonist rosiglitazone, an endogenous transcriptional activator of Ucp2, does not significantly alter RGC loss during glaucoma, suggesting differences in regulation of the protective transgene and the endogenous gene. We additionally hypothesized that deletion of Ucp2 in either RGCs or retinal glia would increase retinal damage and retinal ganglion cell death in a mouse model of glaucoma. Paradoxically, we found the reverse, and deletion of mitochondrial UCP2 decreased oxidative protein modification and reduced retinal ganglion cell death in male and female mice. This paradox was resolved after finding that Ucp2 deletion also increased levels of mitophagy in cell culture and retinal tissue. Together, our data show that both Ucp2 deletion and elevated Ucp2 expression facilitate increased mitochondrial function, either by reducing the generation of reactive oxygen species or by improving quality control, though transcriptional activation alone is insufficient to elicit this neuroprotective effect, motivating further research into the post-transcriptional regulation of Ucp2. These data support a model whereby certain forms of increased Ucp2 expression mediate neuroprotection during long-term oxidative stress, and may provide a therapeutic avenue for other chronic neurodegenerative conditions.

ISBN: 9781392318461Subjects--Topical Terms:

588700
Neurosciences.

UCP2-Dependent Changes in Mitochondrial Dynamics Protect the Retina from Glaucoma.
LDR:03143nmm a2200313 4500 001 2207731
005 20190920102411.5
008 201008s2019 ||||||||||||||||| ||eng d
020 $a 9781392318461
035 $a (MiAaPQ)AAI13917913
035 $a AAI13917913
040 $a MiAaPQ $c MiAaPQ
100 1 $a Hass, Daniel T. $3 3434723
245 1 0 $a UCP2-Dependent Changes in Mitochondrial Dynamics Protect the Retina from Glaucoma.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 132 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-12, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Barnstalde, Colin J.
502 $a Thesis (Ph.D.)--The Pennsylvania State University, 2019.
520 $a Glaucoma is a neurodegenerative disorder characterized by mitochondrial dysfunction and an increase in oxidative damage, leading to progressive retinal ganglion cell (RGC) degeneration. The oxidative status of RGCs is regulated intrinsically and also extrinsically by retinal glia. The mitochondrial uncoupling protein 2 (UCP2) relieves oxidative and neuronal damage in a variety of neurodegenerative disease models. However, the impact of Ucp2 on cell survival during sub-acute and chronic neurodegenerative conditions is not yet clear. Herein, we test the hypothesis that increased Ucp2 expression will improve retinal ganglion cell survival in a mouse model of glaucoma. We show that increasing retinal ganglion cell but not glial Ucp2 expression in transgenic animals decreases glaucomatous RGC death, but also that the PPAR-γ agonist rosiglitazone, an endogenous transcriptional activator of Ucp2, does not significantly alter RGC loss during glaucoma, suggesting differences in regulation of the protective transgene and the endogenous gene. We additionally hypothesized that deletion of Ucp2 in either RGCs or retinal glia would increase retinal damage and retinal ganglion cell death in a mouse model of glaucoma. Paradoxically, we found the reverse, and deletion of mitochondrial UCP2 decreased oxidative protein modification and reduced retinal ganglion cell death in male and female mice. This paradox was resolved after finding that Ucp2 deletion also increased levels of mitophagy in cell culture and retinal tissue. Together, our data show that both Ucp2 deletion and elevated Ucp2 expression facilitate increased mitochondrial function, either by reducing the generation of reactive oxygen species or by improving quality control, though transcriptional activation alone is insufficient to elicit this neuroprotective effect, motivating further research into the post-transcriptional regulation of Ucp2. These data support a model whereby certain forms of increased Ucp2 expression mediate neuroprotection during long-term oxidative stress, and may provide a therapeutic avenue for other chronic neurodegenerative conditions.
590 $a School code: 0176.
650 4 $a Neurosciences. $3 588700
650 4 $a Ophthalmology. $3 862704
650 4 $a Biochemistry. $3 518028
690 $a 0317
690 $a 0381
690 $a 0487
710 2 $a The Pennsylvania State University. $b Neuroscience. $3 3434724
773 0 $t Dissertations Abstracts International $g 80-12B.
790 $a 0176
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13917913